Introduction {#s1}
============

Major depression (MD) is a severe mental illness that causes heavy social and economic burdens worldwide ([@CIT0075]). It has been estimated that more than 30 million people suffer from MD in Europe, with a prevalence of 6.9% each year ([@CIT0072]). Stress-related psychiatric disorders such as depression are complex diseases and, although the pathophysiology of MD is still essentially unknown, several lines of evidence show that the interplay between individual genetic vulnerability and environmental risk factors, such as stress, may precipitate pathology ([@CIT0010]; [@CIT0009]; [@CIT0032]). Indeed, stressful adverse events in childhood (early-life stress) have been found to increase the likelihood of developing the pathology in adult life ([@CIT0021]; [@CIT0011]; [@CIT0048]).

In this study, to reproduce the gene x environment (GxE) interaction we employed an animal model that combines genetic vulnerability with early-life stress ([@CIT0076]; [@CIT0024]; [@CIT0034]; [@CIT0044]; [@CIT0055]; [@CIT0071]). Therefore, we subjected a genetic animal model of depression, the Flinders Sensitive Line (FSL) rats, to a standard protocol of maternal separation (MS; [@CIT0056]). Indeed, MS has been shown to induce hypothalamic-pituitary-adrenal axis alteration, decrease saccharin intake, and increase anxiety-like behavior ([@CIT0069]; [@CIT0019]; [@CIT0034]). The FSL rats, a well-validated animal model of depression, were genetically selected from Sprague-Dawley rats for their sensitivity to cholinergic agents ([@CIT0050]). They address the validation criteria of construct, face, and predictive validity for a good animal model. In fact, the FSL rats display many features of depressed individuals, such as reduced general activity, decreased appetite and body weight, decreased libido, alteration of REM sleep, anhedonia (after stress), and biochemical and behavioral abnormalities ([@CIT0049]; [@CIT0027]; [@CIT0047]; [@CIT0051]). However, it is worth mentioning that, like other selectively-bred animal models of depression, FSL rats exhibit some similarities to depressed humans, but cannot reproduce all features of human pathology. For instance, FSL rats in non-stressed conditions do not show anhedonia, a key symptom of depression in humans. Therefore, all conclusions of the present study must be taken with the caveat that FSL, like other animal models, cannot explain all aspects of pathology.

Proteomics allows the simultaneous analysis of hundreds of proteins and is a powerful approach to gain insight into the molecular mechanisms underlying vulnerability to psychiatric disorders and response to stress ([@CIT0058]; [@CIT0018]; [@CIT0070]; [@CIT0034]). Thus, proteomic analysis allows us to move beyond the single gene/protein/pathway and to explore multiple biological pathways and functions related to the pathophysiology of MD.

In this study, we carried out a global proteomics analysis of purified synaptic terminals (synaptosomes) from the prefrontal and frontal cortices (PFC/FC) and hippocampi (HPC) of FSL rats and their controls, the Flinders Resistant Line (FRL) rats, in order to study a subcellular compartment enriched in proteins involved in synaptic function. Thus, two-dimensional gel electrophoresis (2-DE), mass spectrometry, and bioinformatic analysis were used to analyze proteins and related functional networks that are modulated by genetic susceptibility (FSL vs. FRL) or by exposure to early-life stress (FRL + MS vs. FRL and FSL + MS vs. FSL).

We found that, at a synaptic level, proteins and molecular pathways related to energy metabolism and cellular remodeling were mainly dysregulated.

Methods {#s2}
=======

Animals {#s3}
-------

FSL and FRL from the rat colonies maintained at the Karolinska Institutet were housed in standard cages (26 x 42 x 15cm) on a 12h light/dark cycle (lights on at 07:00 hours) with controlled room temperature (22±1°C) and relative humidity (45--55%). Food (Lactamin R36) and tap water were available *ad libitum*. Stockholm's Ethical Committee for the Protection of Animals approved the study, and all animal handling and procedures were conducted in conformity with the Karolinska Institutet's Guidelines for the Care and Use of Laboratory Animals, in accordance with the European Community Council Directive 86/609/EEC. All efforts were made to minimize animal distress and to reduce the numbers of animals used in this study.

Maternal Separation {#s4}
-------------------

A standard MS procedure was carried out as described before ([@CIT0056]; [@CIT0016]). Briefly, the day of delivery was designated as postnatal day (PND) 0. Litters from each rat strain were randomly assigned to the MS group and were separated from the dam for 180min/day from PND 2 to PND 14, beginning at 10:00 hours. Dams were removed from the home cages and placed in a new individual cage, then litters were removed from the nest and placed in clean plastic chambers in a incubator at 30--33°C. At the end of the separation period, first the litters and then the dams were returned to the home cages. Control litters were left undisturbed and not handled at any time except for during changes of bedding twice a week. After weaning at PND 22, rats were housed in groups of three to five per cage. Only male rats were used in this study ([Figure 1](#F1){ref-type="fig"}).

![Schematic representation of the experimental design. Flinders Resistant Line (FRL) and Flinders Sensitive Line (FSL) rats were separated from the dam for 180min/day from postnatal day (PND) 2 to PND 14. Control FSL and FRL rats were not separated. All rats were weaned at PND 22. On PND 73 animals were sacrificed and prefrontal and frontal cortices (PFC/FC) and hippocampi (HPC) were removed.](ijnppy_pyu067_f0001){#F1}

Purification of Synaptosomes {#s5}
----------------------------

Synaptosomes were prepared from FSL/FRL rats at the Karolinska Institutet, and synaptosome pellets were frozen and transferred for processing. Rats (16--20 per experimental group) were sacrificed on PND 73, the HPC and the whole frontal lobe (PFC/FC) were dissected on ice according to brain atlas coordinates (for PFC/FC plates 4--11; [@CIT0053]), and synaptosomes were prepared by the Percoll gradient procedure according to [@CIT0015], with minor modifications ([@CIT0034]; [@CIT0044]), from fresh brain tissue. Briefly, HPC or PFC/FC were homogenized in 10vol of homogenization buffer (0.28M sucrose, 10mM HEPES pH 7.4, 0.1mM EGTA, 20mM NaF, 5mM Na~2~PO~4~, 1mM Na~3~VO~4~, and 2 µl/ml protease inhibitor cocktail \[Sigma Aldrich\]) using a glass/teflon tissue grinder with clearance of 0.25mm. The homogenate was centrifuged 5min at 1 000 *g*, the supernatant was stratified on a discontinuous Percoll gradient (6, 10, and 20% v/v in Tris-buffered sucrose) and centrifuged at 33 500 *g* for 5min. The layer between 10 and 20% Percoll (synaptosomes) was collected and washed by centrifugation, and the resulting pellet was stored at -80°C.

2-DE and Proteome Analysis {#s6}
--------------------------

### 2-DE and Imaging {#s7}

2-DE was carried out as previously described ([@CIT0034] [@CIT0035]). Synaptosome pellets were dissolved in isoelectric focusing (IEF) buffer (7M urea, 2M thiourea, 40mM Tris, 3mM tributylphosphine, 2% CHAPS, 1% carrier ampholytes \[GE Healthcare\], and protease inhibitors \[Roche Diagnostic\]). An aliquot of each pellet was dialyzed in 1% sodium dodecyl sulfate in distilled water to measure protein concentration by bicinchoninic acid assay (Pierce Chemical). Next, 115 µg of synaptosomes were dissolved in 125 µl of IEF buffer containing 10mM iodoacetamide as an alkylating agent and a trace of bromophenol blue, and separated by IEF in 7cm pH 3--10 non-linear immobilized pH gradient (IPG) strips (Bio-Rad). IEF was performed at 15°C at a maximum of 4000V for a total of 28 000 Vh using Protean IEF Cell (Bio-Rad).

Prior to the second dimension, the IPG strips were equilibrated in a solution containing 6M urea, 2% SDS, 375mM Tris pH 8.8, and 4mM tributylphosphine. After equilibration, the IPG strips were placed on top of 8--18% T-gradient polyacrylamide gels, and sealed with 0.5% agarose in running buffer. The 2-DE gels were then fixed and stained with SYPRO Ruby (Bio-Rad). The 2-DE gel images were digitally acquired by VersaDoc imaging system (Bio-Rad). Image and statistical analysis were carried out by PDQuest software (Bio-Rad), to compare replicate groups and identify sets of protein spots that show a statistically significant difference with a confidence level of 0.05.

### Mass Fingerprinting and Protein Identification {#s8}

Differently expressed spots were cut from gel with a spot cutter (Bio-Rad), digested with trypsin, and identified by peptide mass fingerprinting at the Proteomics Core Facility of the University of Geneva ([@CIT0061]). Mascot (Matrix Science Ltd.; Perkins et al., 1999) and Profound software (PROWL; <http://prowl.rockefeller.edu/prowl-cgi/profound.exe>) and Aldente tools (<http://au.expasy.org/cgi-bin/aldente/form.cgi>) were used to analyze spectra. The research was conducted against SWISS-PROT, TrEMBL, and NCBInr databases.

Western Blot Analysis {#s9}
---------------------

Western blotting was carried out as previously described ([@CIT0044]). Briefly, synaptosomal proteins were separated on 12% polyacrylamide gels and blotted on polyvinylidene fluoride membranes (GE Healthcare). Blocking was performed for 1 hour at room temperature in 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20 (TBST). Membranes were then incubated overnight in 5% nonfat dry milk in TBST with primary antibodies for aconitate hydratase (1:2000, a generous gift from Professor Szweda, Oklahoma Medical Research Foundation), N-ethylmaleimide sensitive factor (NSF, 1:1000, Cell Signalling Technology Inc.), syntaxin-binding protein 1 (1:3000, BD Biosciences Italy), adenosine triphosphate synthase alpha (1:3000, Life Technologies Italia), synaptosomal-associated protein 25 (SNAP-25, 1:2000, Synaptic Systems GmbH), dihydropyrimidinase-related protein 2 (DRP-2, 1:2000, Sigma-Aldrich), and β-actin (1:10000, Sigma-Aldrich). Following incubation with peroxidase-coupled secondary antibodies, protein bands were visualized with StoS Protein Detection System (GeneSpin) on Hyperfilm ECL films (GE Healthcare). All protein bands used were within linear range, and normalized for β-actin levels in the same membrane. Quantity One software (Bio-Rad) was used for standardization and quantitation.

Bioinformatic Analysis {#s10}
----------------------

Functional, canonical pathways and networks analyses were generated using Ingenuity Pathways Analysis (IPA, Ingenuity Systems, <http://www.ingenuity.com>). All proteins identified by mass spectrometry were considered for the analyses. The software identified the biological functions/canonical pathways in the Ingenuity Pathways Knowledge Base that were most significant to the data set. Fischer's exact test was used to calculate a *p*-value determining the probability that each biological function assigned to that data set is due to chance alone. For network generation, a data set containing protein identifiers and relative fold change values was uploaded into the application and mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base. Networks of these focus genes were then algorithmically generated based on their connectivity. Fischer's exact test was used to calculate a *p*-value determining the probability that each biological function assigned to that network is due to chance alone. The *p*-value is then expressed as a score (i.e. -log~10~ *p*-value); a score of 8 or higher is considered extremely significant.

Statistical Analysis {#s11}
--------------------

In the proteomic study, protein spot intensities were first log transformed to fit the normal distribution curve and then analyzed with student's *t*-tests and Partial Least Squares tests using PDQuest software. Unpaired two-tailed non-parametric Mann-Whitney tests were used to analyze Western blotting data using GraphPad Prism 4 (GraphPad Software Inc.). In both proteomic and Western blotting analyses, significance was assumed at *p* \< 0.05.

Results {#s12}
=======

In this study we employed 2-DE to analyze basal differences in synaptosomal protein expression patterns in FSL and FRL rats. Moreover, the long-term effect of early-life stress on the synaptosomal protein expression pattern was assessed in both rat lines. In addition, IPA was used to identify the biological functions and cellular processes most relevant to the differently-expressed proteins, and to explore relative pathways/networks of the proteins involved.

Synaptosomal Proteome Maps {#s13}
--------------------------

PFC/FC and HPC synaptosomes were prepared from FSL and FRL rats, naïve or subjected to MS. Proteins were separated by 2-DE gels and only proteomic maps belonging to the same electrophoretic run were analyzed in the same match-set in order to reduce experimental variability. Examples of rat PFC/FC and HPC 2-DE maps are reported in [Figure 2](#F2){ref-type="fig"}.

![Representative two-dimensional gel electrophoresis gel images of Sypro-Ruby-stained synaptosomal proteins from (A) prefrontal and frontal cortices or (B) hippocampi in FSL rats. Circles and numbers indicate differently-regulated proteins spots (see also Tables 2 and 3).](ijnppy_pyu067_f0002){#F2}

The map containing the largest number of spots was chosen as the reference master map and the corresponding spots in all gels were matched. The average spot number (± standard deviation \[SD\]) detected in a gel was 470±53 in PFC/FC, with an average percentage of matched spots across gels of 87%. In HPC, the average number of spots (± SD) detected was 370±15, with an average percentage of matched spots across gels of 96.5%.

The following comparisons between experimental groups were carried out in both brain areas: FSL vs. FRL, to evaluate basal (genetic) differences between rat lines; FRL + MS vs. FRL; and FSL + MS vs. FSL to evaluate the effects of GxE interaction.

The number of spots differently modulated in the different comparisons are reported in [Table 1](#T1){ref-type="table"}. Spots with statistically significant different levels were excised from gels and identified by peptide mass fingerprinting analysis ([Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"}).

###### 

Comparisons of Experimental Groups

  Comparison       Spots per gel (mean ± [SD]{.smallcaps})   \% of matched spots (mean)   Modulated spots   *t*-test   PLS   Common to *t*-test and PLS
  ---------------- ----------------------------------------- ---------------------------- ----------------- ---------- ----- ----------------------------
  PFC/FC                                                                                                                     
  FSL vs. FRL      497±62                                    88                           27                25         11    9
  FRL+MS vs. FRL   436±28                                    86                           19                14          9     4
  FSL+MS vs. FSL   504±51                                    88                           43                34         20    11
  HPC                                                                                                                        
  FSL vs. FRL      376±14                                    96                           17                15         10     8
  FRL+MS vs. FRL   372±6                                     96                           19                17          7     5
  FSL+MS vs. FSL   368±21                                    97                           19                14          9     4

The average number of spots per gel with standard deviation (SD) is reported in column 2 for the considered comparison. The average percentage of gel spots matched with the standard map for each comparison set is reported in column 3. Two statistical tests were performed: student's *t*-test and Partial Least Squares analysis (PLS). The total number of spots showing a statistically-significant modulation in student's *t*-test (*t*-test, *p* \< 0.05, column 5) or in PLS analysis (95% significance level, column 5) and the number of shared spots between the two tests are indicated (column 6). HPC, hippocampus; MS, maternal separation; PFC/FC, prefrontal and frontal cortices.

###### 

Proteins Identified by Mass-Spectrometry in PFC/FC

  Spot No.^a^                                    Protein name                                                                     Acc. No.^b^   No. of matched peptides   Coverage (%)^c^   Mascot score   Fold change   T-test   PLS^d^
  ---------------------------------------------- -------------------------------------------------------------------------------- ------------- ------------------------- ----------------- -------------- ------------- -------- --------
  Spot differently modulated in FSL vs. FRL                                                                                                                                                                                       
  308                                            ATPase H^+^ transporting, V0 subunit D isoform 1                                 Q5M7T6        6                         15                56             1,4           Y        N
  1209                                           Pyruvate dehydrogenase E1 component subunit beta, mitochondrial                  Q6AY95        7                         22                50             2,5           Y        N
  1706                                           NADH-ubiquinone oxidoreductase 75kDa subunit, mitochondrial                      Q66HF1        12                        16                68             -1,8          Y        N
  Heat shock cognate 71 kDA protein              P63018                                                                           16            27                        113                                                     
  2605                                           Histamine N-methyltransferase                                                    Q01984        6                         17                38             1,6           Y        N
  3201                                           Peroxiredoxin 6                                                                  O35244        4                         17                28             1,5           Y        N
  3404                                           Isocitrate dehydrogenase \[NAD\] subunit alpha, mitochondrial precursor          Q99NA5        7                         21                42             1,1           Y        N
  5404                                           Fructose bisphosphate aldolase C                                                 P09117        5                         19                31             1,5           Y        N
  5607                                           Syntaxin-binding protein 1                                                       P61765        11                        17                57             -3,0          Y        N
  5807                                           Dynamin-1                                                                        P21575        24                        23                174            -1,7          Y        N
  7601                                           Transketolase                                                                    P50137        7                         13                45             3,4           N        Y
  Spot differently modulated in FRL+MS vs. FRL                                                                                                                                                                                    
  1209                                           Pyruvate dehydrogenase E1 component subunit beta, mitochondrial                  Q6AY95        7                         22                50             1,8           N        Y
  1308                                           Guanine nucleotide binding protein G(o) alpha subunit 2                          P30033        9                         25                63             -2,1          Y        Y
  Calcium binding protein 39-like                Q5XIJ7                                                                           7             13                        40                                                      
  1706                                           NADH-ubiquinone oxidoreductase 75kDa subunit, mitochondrial                      Q66HF1        12                        16                68             1,2           Y        N
  Heat shock cognate 71 kDA protein              P63018                                                                           16            27                        113                                                     
  1707                                           NADH-ubiquinone oxidoreductase 75kDa subunit, mitochondrial                      Q66HF1        16                        26                115            -1,6          Y        Y
  Heat shock cognate 71 kDA protein              P63018                                                                           8             15                        38                                                      
  2601                                           60kDa heat shock protein, mitochondrial precursor                                P63039        15                        30                108            -1,1          Y        N
  3201                                           Peroxiredoxin-6                                                                  O35244        4                         17                28             -1,3          Y        N
  3404                                           Isocitrate dehydrogenase \[NAD\] subunit alpha, mitochondrial precursor          Q99NA5        7                         21                42             -1,9          Y        Y
  5404                                           Fructose-biphosphate aldolase C                                                  P09117        5                         19                31             -1,3          Y        N
  8306                                           Malate dehydrogenase, mitochondrial                                              P04636        10                        34                75             -1,4          Y        N
  Glyceraldehyde-3-phosphate dehydrogenase       P04797                                                                           6             25                        43                                                      
  Spot differently modulated in FSL+MS vs. FSL                                                                                                                                                                                    
  207                                            14-3-3 protein zeta/delta                                                        P63102        13                        40                89             1,5           Y        N
  14-3-3 protein eta                             P68511                                                                           9             29                        58                                                      
  14-3-3 protein beta/alpha                      P35213                                                                           9             27                        51                                                      
  14-3-3 protein gamma                           P61983                                                                           8             27                        44                                                      
  306                                            Clathrin light chain B                                                           P08082        6                         17                60             -1,8          Y        Y
  308                                            ATPase H+ trasporting V0 subunit D, isoform 1                                    Q5M7T6        6                         15                56             -1,6          Y        N
  1106                                           NADH-ubiquinone oxidoreductase 23kDa subunit, mitochondrial precursor (mouse)    Q8K3J1        4                         19                31             -1,4          Y        N
  2202                                           Prohibitin                                                                       P67779        7                         31                57             -1,6          Y        N
  2203                                           NADH-ubiquinone oxidoreductase 30 kDA subunit, mitochondrial precursor (mouse)   Q9DCT2        8                         25                71             -2,4          Y        Y
  2207                                           NADH-ubiquinone oxidoreductase 30 kDA subunit, mitochondrial precursor (mouse)   Q9DCT2        7                         27                57             -1,7          Y        N
  2209                                           Prohibitin                                                                       P67779        7                         31                68             -1,8          Y        Y
  2302                                           Guanine nucleotide binding protein G(o) alpha subunit 2                          P30033        6                         19                35             -1,5          Y        N
  3201                                           Peroxiredoxin 6                                                                  O35244        4                         17                28             -1,6          Y        N
  3309                                           Cytosolic malate dehydrogenase                                                   O88989        9                         28                60             -1,4          Y        N
  5103                                           Cytochrome C1 protein fragment (mouse)                                           Q63ZW4        5                         18                31             -1,5          Y        N
  5306                                           Voltage-dependent anion selective channel protein 1                              Q9Z2L0        5                         23                45             -1,2          Y        N
  5607                                           Syntaxin-binding protein 1                                                       P61765        11                        17                57             1,9           Y        N
  5704                                           N-ethylmaleimide sensitive factor                                                Q9QUL6        8                         13                36             -1,2          Y        N
  6610                                           Pyruvate kinase isozymes M1/M2                                                   P11980        12                        19                69             -1,8          N        Y
  6710                                           Aconitate hydratase, mitochondrial precursor                                     Q9ER34        20                        25                147            -1,3          Y        N
  7407                                           Creatine kinase mitochondrial 1, ubiquitous                                      Q5BJT9        13                        30                97             1,8           N        Y
  7507                                           ATP synthase alpha chain, mitochondrial precursor                                P15999        11                        23                68             -2,3          N        Y
  7601                                           Transketolase                                                                    P50137        7                         13                45             -3,1          Y        N
  8502                                           ATP synthase alpha chain, mitochondrial precursor                                P15999        14                        26                88             -1,8          N        Y

^a^Protein spot number as indicated in [Figure 2A](#F2){ref-type="fig"}

^b^SwissProt or TrEMBL database accession number

^c^Percentage of identified sequence of the known protein

^d^Partial Least Square

ATP, adenosine triphosphate; FRL, Flinders Resistant Line; FSL, Flinders Sensitive Line; MS, maternal separation; PFC/FC, prefrontal and frontal cortices.

###### 

Proteins Identified by Mass-Spectrometry in HPC

  Spot No.^a^                                                               Protein name                                                                               Acc. No.^b^   No. of matched peptides   Coverage (%)^c^   Mascot score   Fold change   T-test   PLS^d^
  ------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ------------- ------------------------- ----------------- -------------- ------------- -------- --------
  Spot differently modulated in FSL vs. FRL                                                                                                                                                                                                                            
  601                                                                       Beta actin, cytoplasmic 1                                                                  P60711        7                         22                18             -3,9          N        Y
  903                                                                       Neurofilament light polypeptide                                                            P19527        14                        25                81             -2,0          N        Y
  1602                                                                      Beta actin, cytoplasmic 1                                                                  P60711        13                        31                82             2,8           Y        Y
  2203                                                                      NADH-dehydrogenase \[ubiquinone\] iron-sulfur protein 3, mitochondrial precursor (mouse)   Q9DCT2        6                         22                35             1,1           Y        N
  2403                                                                      Beta actin, cytoplasmic 1                                                                  P60711        11                        29                73             1,8           Y        Y
  Gamma actin, cytoplasmic 2                                                P63259                                                                                     11            29                        73                                                      
  Guanine nucleotide binding prot. G(o) subunit alpha 2                     P30033                                                                                     6             19                        27                                                      
  3404                                                                      Beta actin, cytoplasmic 1                                                                  P60711        10                        29                78             4,4           Y        N
  Gamma actin, cytoplasmic 2                                                P63259                                                                                     10            29                        78                                                      
  Guanine nucleotide binding prot. G(o) subunit alpha 2                     P30033                                                                                     6             19                        34                                                      
  3602                                                                      Beta actin, cytoplasmic 1                                                                  P60711        10                        34                90             1,3           Y        N
  4503                                                                      Succinyl-CoA ligase \[ADP-forming\] beta chain, mitochondrial precursor (mouse)            Q9Z2I9        8                         12                44             -2,1          Y        Y
  4902                                                                      Dihydropyrimidinase-related protein 2                                                      P47942        8                         15                56             1,8           Y        Y
  5902                                                                      N-ethylmaleimide sensitive factor                                                          Q9QUL6        14                        18                65             -1,1          Y        N
  9501                                                                      Aspartate aminotransferase, mitochondrial precursor                                        P00507        15                        31                145            1,4           Y        N
  Spot differently modulated in FRL+MS vs. FRL                                                                                                                                                                                                                         
  101                                                                       Synaptosomal-associated protein 25                                                         P60881        10                        54                79             1,3           Y        Y
  604                                                                       NSFL1 cofactor p47                                                                         O35987        12                        37                108            -7,2          Y        N
  Beta actin, cytoplasmic 1                                                 P60711                                                                                     9             26                        67                                                      
  Gamma enolase                                                             P07323                                                                                     7             19                        44                                                      
  1103                                                                      NADH dehydrogenase \[ubiquinone\] flavoprotein 2, mitochondrial precursor                  P19234        9                         45                77             -1,4          Y        N
  Rho GDP-dissociation inhibitor 1 (mouse)                                  Q99PT1                                                                                     7             37                        53                                                      
  1903                                                                      Heat shock cognate 71kDa protein                                                           P63018        20                        34                111            -3,6          Y        Y
  Heat shock-related 70kDa protein 2                                        P14659                                                                                     10            16                        31                                                      
  1907                                                                      Heat shock cognate 71kDa protein                                                           P63018        21                        37                201            -7,5          Y        N
  Heat shock-related 70kDa protein 2                                        P14659                                                                                     9             15                        52                                                      
  2704                                                                      Vacuolar ATP synthase subunit B, brain isoform                                             P62815        8                         17                54             -1,8          N        Y
  2902                                                                      Heat shock cognate 71kDa protein                                                           P63018        18                        32                156            -1,4          Y        N
  3002                                                                      Superoxide dismutase \[Cu-Zn\]                                                             Q6LDS4        5                         26                49             1,2           Y        N
  3201                                                                      Prohibitin                                                                                 P67779        9                         30                59             -1,2          Y        N
  3402                                                                      Beta actin, cytoplasmic 1                                                                  P60711        10                        34                80             -1,8          Y        Y
  Isocitrate dehydrogenase \[NAD\] subunit alpha, mitochondrial precursor   Q99NA5                                                                                     6             20                        35                                                      
  5201                                                                      Vacuolar ATP synthase subunit E1                                                           Q6PCU2        9                         30                62             1,2           Y        N
  5805                                                                      Dihydropyrimidinase-related protein 2                                                      P47942        5                         10                17             -100,0        Y        N
  7701                                                                      Glutamate dehydrogenase 1, mitochondrial precursor                                         P10860        18                        28                70             1,9           Y        Y
  ATP synthase subunit alpha, mitochondrial precursor                       P15999                                                                                     14            26                        61                                                      
  Vimentin                                                                  P31000                                                                                     14            24                        56                                                      
  7705                                                                      ATP synthase subunit alpha, mitochondrial precursor                                        P15999        12                        23                93             -1,9          Y        N
  8101                                                                      Superoxide dismutase \[Mn\], mitochondrial precursor                                       P07895        5                         23                45             -1,1          Y        N
  8506                                                                      Isocitrate dehydrogenase \[NAD\] subunit beta, mitochondrial precursor                     Q68FX0        12                        25                77             -2,2          Y        Y
  Aspartate aminotransferase, cytoplasmic                                   P13221                                                                                     8             16                        47                                                      
  Spot differently modulated in FSL+MS vs. FSL                                                                                                                                                                                                                         
  201                                                                       14-3-3 protein zeta/delta                                                                  P63102        15                        45                77             1,3           Y        N
  14-3-3 protein theta                                                      P68255                                                                                     10            30                        42                                                      
  14-3-3 protein gamma                                                      P61983                                                                                     9             31                        37                                                      
  14-3-3 protein alpha/beta                                                 P35213                                                                                     9             26                        36                                                      
  14-3-3 protein eta                                                        P68511                                                                                     8             26                        26                                                      
  903                                                                       Neurofilament light polypeptide                                                            P19527        14                        25                81             2,0           N        Y
  1804                                                                      Alpha-internexin                                                                           P23565        17                        29                64             -1,8          N        Y
  60kDa heat shock protein, mitochondrial precursor                         P63039                                                                                     9             18                        35                                                      
  1805                                                                      Alpha-internexin                                                                           P23565        22                        31                199            2,8           N        Y
  Neurofilament light polypeptide                                           P19527                                                                                     9             12                        48                                                      
  1905                                                                      Heat shock cognate 71kDa protein                                                           P63018        15                        25                59             1,5           Y        N
  NADH-ubiquinone oxidoreductase 75kDa subunit, mitochondrial precursor     Q66HF1                                                                                     10            14                        32                                                      
  1911                                                                      Mitochondrial inner membrane protein (mouse)                                               Q8CAQ8        12                        15                57             1,7           N        Y
  2901                                                                      Heat shock cognate 71kDa protein                                                           P63018        23                        38                61             1,3           Y        N
  Heat shock-related 70kDa protein 2                                        P14659                                                                                     16            24                        24                                                      
  3701                                                                      Vacuolar ATP synthase subunit B, brain isoform                                             P62815        13                        27                113            1,1           Y        N
  4905                                                                      Dihydropyrimidinase-related protein 2                                                      P47942        9                         18                62             -2,1          N        Y
  5603                                                                      Elongation factor Tu, mitochondrial precursor (mouse)                                      Q8BFR5        11                        28                95             -1,4          Y        N
  6602                                                                      Calcium/calmodulin-dependent protein kinase type II alpha chain                            P11275        8                         18                53             4,5           Y        N
  6702                                                                      Glutamate dehydrogenase 1, mitochondrial precursor                                         P10860        16                        29                83             -1,4          Y        N
  ATP synthase subunit alpha, mitochondrial precursor                       P15999                                                                                     11            20                        38                                                      
  8504                                                                      Phosphoglycerate kinase 1                                                                  P16617        8                         18                44             -1,9          Y        Y
  8703                                                                      ATP synthase subunit alpha, mitochondrial precursor                                        P15999        22                        38                135            -3,6          Y        Y

^a^Protein spot number as indicated in [Figure 2B](#F2){ref-type="fig"}

^b^SwissProt or TrEMBL database accession number

^c^Percentage of identified sequence of the known protein

^d^Partial Least Square

ATP, adenosine triphosphate; FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; MS, maternal separation.

Prefrontal and Frontal Cortices Synaptoproteomics {#s14}
-------------------------------------------------

### Basal Differences Between FSL-FRL in the Prefrontal and Frontal Cortices {#s15}

2-DE proteomic analysis revealed 27 differently-expressed protein spots between FSL and FRL rats. Among them, 10 were successfully identified by mass spectrometry, representing 11 distinct proteins (one spot containing a mixture of two proteins; [Table 2](#T2){ref-type="table"}). IPA functional analysis tool identified the biological functions relevant to the upregulated or downregulated proteins in basal comparison ([Figure 3A](#F3){ref-type="fig"}). The top three molecular and cellular functions identified were nucleic acid metabolism, small molecule biochemistry, and energy production ([Table 4](#T4){ref-type="table"}). Moreover, IPA was used to explore canonical pathways statistically relevant in the same comparison. The top three canonical pathways were pentose phosphate pathway, acetyl-CoA biosynthesis, and sucrose degradation ([Figure 3B](#F3){ref-type="fig"} and [Table 5](#T5){ref-type="table"}).

![Bioinformatic analysis in the prefrontal and frontal cortices. Major biological functions and cellular processes most relevant to the proteins differently expressed in: (A) Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (C) FRL after maternal separation (MS), and (E) FSL after MS, as calculated by Ingenuity Pathways Analysis software. Canonical pathways most relevant to the proteins differently expressed in: (B) FSL vs. FRL, (D) FRL after MS, and (F) FSL after MS. Biological functions and canonical pathways are listed based on higher statistical significance \[-log(p value)\], with a threshold set at 1.3.](ijnppy_pyu067_f0003){#F3}

###### 

Molecular and Cellular Functions Identified by IPA in PFC/FC and HPC

  Molecular and Cellular Functions             *p*-value   Proteins^a^
  -------------------------------------------- ----------- -------------------------------------------------------------------------------------------------------
  FSL vs. FRL (PFC/FC)                                     
  Nucleic Acid Metabolism                      2,49E-06    HSPA8, NDUFS1, TKT, ATP6V0D1, IDH3A, PDHB
  Small Molecule Biochemistry                  2,49E-06    HSPA8, STXBP1, NDUFS1, HNMT, TKT, ATP6V0D1, IDH3A, PDHB, PRDX6
  Energy Production                            4,91E-05    HSPA8, NDUFS1, ATP6V0D1
  Cellular Assembly and Organization           9,52E-05    DNM1, HSPA8, NDUFS1, STXBP1
  Cellular Function and Maintenance            9,52E-05    HSPA8, DNM1, NDUFS1, STXBP1
  FRL+MS vs. FRL (PFC/FC)                                  
  Nucleic Acid Metabolism                      1,59E-06    HSPA8, NDUFS1, GNAO1, GAPDH, IDH3A, HSPD1, MDH2, PDHB
  Small Molecule Biochemistry                  1,59E-06    HSPA8, NDUFS1, GNAO1, GAPDH, IDH3A, HSPD1, MDH2, PDHB, PRDX6
  Post-Translational Modification              3,39E-05    HSPA8, HSPD1, PRDX6, ALDOC
  Protein Folding                              3,39E-05    HSPA8, HSPD1
  Cell Death and Survival                      1,36E-04    HSPA8, NDUFS1, GNAO1, GAPDH, HSPD1, PRDX6, ALDOC
  FSL+MS vs. FSL (PFC/FC)                                  
  Nucleic Acid Metabolism                      4,53E-06    NSF, ATP5A1, TKT, GNAO1, ATP6V0D1, PKM, CKMT1A/CKMT1B, MDH1, VDAC1
  Small Molecule Biochemistry                  4,53E-06    STXBP1, YWHAH, TKT, ATP5A1, PKM, ACO2, CKMT1A/CKMT1B, YWHAZ, MDH1, PRDX6, NSF, ATP6V0D1, GNAO1, VDAC1
  Molecular Transport                          7,63E-06    STXBP1, YWHAH, YWHAB, ATP5A1, PKM, YWHAZ, CKMT1A/CKMT1B, MDH1, PRDX6, NSF, GNAO1, ATP6V0D1, VDAC1
  DNA Replication, Recombination, and Repair   2,81E-04    NSF, ATP5A1, ATP6V0D1, GNAO1, CKMT1A/CKMT1B
  Energy Production                            2,81E-04    NSF, ATP5A1, ATP6V0D1, PKM, MDH1, VDAC1
  FSL vs. FRL (HPC)                                        
  Cellular Assembly and Organization           3,84E-05    DPYSL2, NSF, NEFL, ACTB, GNAO1, ACTG1
  Small Molecule Biochemistry                  8,91E-05    DPYSL2, NSF, SUCLA2, GNAO1, GOT2
  Cell Morphology                              1,76E-04    DPYSL2, NSF, NEFL, ACTB, GNAO1
  Cellular Development                         1,76E-04-   DPYSL2, NEFL, ACTB, GNAO1
  Cellular Function and Maintenance            1,76E-04    DPYSL2, NSF, NEFL, ACTB, GNAO1, ACTG1
  FRL+MS vs. FRL (HPC)                                     
  Free Radical Scavenging                      1,58E-06    SOD2, SOD1, ACTB, ARHGDIA
  Small Molecule Biochemistry                  9,45E-06    DPYSL2, SOD1, ATP5A1, GLUD1, VIM, SNAP25, ATP6V1E1, HSPA8, SOD2, GOT1, IDH3A, IDH3B, ATP6V1B2
  Carbohydrate Metabolism                      1,57E-05    SOD1, SOD2, GOT1, IDH3A, IDH3B
  Amino Acid Metabolism                        3,3E-05     DPYSL2, SOD1, GLUD1, GOT1
  Nucleic Acid Metabolism                      3,42E-05    ATP6V1E1, HSPA8, DPYSL2, SOD2, SOD1, ATP5A1, IDH3A, IDH3B
  FSL+MS vs. FSL (HPC)                                     
  Protein Trafficking                          8,23E-06    YWHAQ, YWHAG, YWHAB, YWHAZ
  Cellular Assembly and Organization           5,09E-05    HSPA8, DPYSL2, NDUFS1, YWHAG, CAMK2A, IMMT, YWHAH, NEFL, YWHAZ, INA
  Cellular Function and Maintenance            5,09E-05    HSPA8, DPYSL2, NDUFS1, YWHAG, CAMK2A, YWHAH, IMMT, NEFL, INA, HSPD1, HSPA2, ATP6V1B2
  Molecular Transport                          7,05E-05    HSPA8, DPYSL2, NDUFS1, CAMK2A, YWHAH, YWHAB, ATP5A1, YWHAZ, ATP6V1B2
  Nucleic Acid Metabolism                      7,3E-05     PGK1, HSPA8, DPYSL2, NDUFS1, ATP5A1, HSPD1

^a^Proteins are indicated with gene name

FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; IPA, Ingenuity Pathways Analysis; MS, maternal separation; PFC/FC, prefrontal and frontal cortices prefrontal cortex.

###### 

Canonical Pathways identified by IPA in PFC/FC and HPC.

  Ingenuity Canonical pathways                                 *p*-value   Proteins^a^
  ------------------------------------------------------------ ----------- -----------------------------------
  FSL vs. FRL (PFC/FC)                                                     
  Pentose Phosphate Pathway (Non-oxidative Branch)             4,25E-03    TKT
  Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase Complex)   4,25E-03    PDHB
  Sucrose Degradation V (Mammalian)                            5,66E-03    ALDOC
  Pentose Phosphate Pathway                                    7,07E-03    TKT
  Glutathione Redox Reactions I                                1,12E-02    PRDX6
  FRL+MS vs. FRL (PFC/FC)                                                  
  Gluconeogenesis I                                            4,4E-07     GAPDH, MDH2, ALDOC
  TCA Cycle II (Eukaryotic)                                    9,39E-05    IDH3A, MDH2
  Glycolysis I                                                 1,2E-04     GAPDH, ALDOC
  NADH Repair                                                  1,93E-03    GAPDH
  Synaptic Long Term Depression                                3,42E-03    GNAO1, PRDX6
  FSL+MS vs. FSL (PFC/FC)                                                  
  Cell Cycle: G2/M DNA Damage Checkpoint Regulation            2,95E-07    YWHAG, YWHAH, YWHAB, YWHAZ
  Myc Mediated Apoptosis Signaling                             1E-06       YWHAG, YWHAH, YWHAB, YWHAZ
  ERK5 Signaling                                               1,4E-06     YWHAG, YWHAH, YWHAB, YWHAZ
  IGF-1 Signaling                                              7,91E-06    YWHAG, YWHAH, YWHAB, YWHAZ
  14-3-3-mediated Signaling                                    1,66E-05    YWHAG, YWHAH, YWHAB, YWHAZ
  FSL vs. FRL (HPC)                                                        
  RhoGDI Signaling                                             1,07E-04    ACTB, GNAO1, ACTG1
  Signaling by Rho Family GTPases                              2,49E-04    ACTB, GNAO1, ACTG1
  Remodeling of Epithelial Adherent Junctions                  7,08E-04    ACTB, ACTG1
  FAK Signaling                                                1,12E-3     ACTB, ACTG1
  VEGF Signaling                                               1,25E-3     ACTB, ACTG1
  FRL+MS vs. FRL (HPC)                                                     
  Superoxide Radicals Degradation                              2,36E-05    SOD1, SOD2
  TCA Cycle II (Eukaryotic)                                    3,93E-04    IDH3A, IDH3B
  Mitochondrial Dysfunction                                    6,73E-04    SOD2, NDUFV2, ATP5A1
  NRF2-mediated Oxidative Stress Response                      1,51E-03    SOD1, SOD2, ACTB
  Glutamate Biosynthesis II                                    2,58E-03    GLUD1
  FSL+MS vs. FSL (HPC)                                                     
  Cell Cycle: G2/M DNA Damage Checkpoint Regulation            1,45E-09    YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
  Myc Mediated Apoptosis Signaling                             6,83E-09    YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
  ERK5 Signaling                                               1,04E-08    YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
  IGF-1 Signaling                                              9,32E-08    YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
  14-3-3-mediated Signaling                                    2,39E-07    YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ

^a^Proteins are indicated with gene name

FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; IPA, Ingenuity Pathways Analysis; MS, maternal separation; PFC/FC, prefrontal and frontal cortices.

### Effect of Early-Life Stress in FRL Prefrontal and Frontal Cortices {#s16}

In FRL rats, MS differently regulated 19 spots and mass spectrometry identified 9 spots representing 13 distinct proteins/protein isoforms (four spots containing a mixture of two proteins; [Table 2](#T2){ref-type="table"}). The three top molecular and cellular functions revealed by IPA analysis were nucleic acid metabolism, small molecule biochemistry, and post-translational modification ([Figure 3C](#F3){ref-type="fig"} and [Table 4](#T4){ref-type="table"}). The top three canonical pathways were gluconeogenesis, TCA cycle, and glycolysis ([Figure 3D](#F3){ref-type="fig"} and [Table 5](#T5){ref-type="table"}).

### Effects of Early-Life Stress in FSL Prefrontal and Frontal Cortices {#s17}

MS differently modulated 43 spots in FSL and mass spectrometry identified 21 spots representing 24 distinct proteins/protein isoforms (one spot containing a mixture of four proteins; [Table 2](#T2){ref-type="table"}). The top three molecular and cellular functions, revealed by bioinformatic analysis with IPA, were nucleic acid metabolism, small molecule biochemistry, and molecular transport ([Figure 3E](#F3){ref-type="fig"} and [Table 4](#T4){ref-type="table"}). The top three canonical pathways were cell cycle (G2/M DNA damage checkpoint regulation), Myc mediated apoptosis signaling, and ERK5 signaling ([Figure 3F](#F3){ref-type="fig"} and [Table 5](#T5){ref-type="table"}).

It is worth mentioning that in the PFC/FC the bioionformatic analysis evidenced biological functions and canonical pathways mostly related to cellular energy metabolism, including the pentose phosphate pathway, acetyl-CoA biosynthesis, sucrose degradation/glycolysis/gluconeogenesis, and TCA cycle ([Table 5](#T5){ref-type="table"}). Moreover, early-life stress modulated twice the number of spots in FSL compared to FRL.

Hippocampus Synaptoproteomics {#s18}
-----------------------------

### Basal Differences Between FSL-FRL in Hippocampus {#s19}

In HPC, 17 protein spots were differently expressed between FSL and FRL rats. Among them, 11 were successfully identified by mass spectrometry, representing 15 distinct proteins/protein isoforms (two spots containing a mixture of three proteins; [Table 3](#T3){ref-type="table"}). The top three biological functions identified by IPA were cellular assembly and organization, small molecule biochemistry, and cell morphology ([Figure 4A](#F4){ref-type="fig"} and [Table 4](#T4){ref-type="table"}). The top three pathways were RhoGDI signaling, signaling by Rho family GTPases, and remodeling of epithelial adherents junctions ([Figure 4B](#F4){ref-type="fig"} and [Table 5](#T5){ref-type="table"}).

![Bioinformatic analysis in the hippocampus. Major biological functions and cellular processes most relevant to the proteins differently expressed in: (A) Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (C) FRL after maternal separation (MS), and (E) FSL after MS, as calculated by Ingenuity Pathways Analysis software. Canonical pathways most relevant to the proteins differently expressed in: (B) FSL vs. FRL, (D) FRL after MS, and (F) FSL after MS. Biological functions and canonical pathways are listed based on higher statistical significance \[-log(p value)\], with a threshold set at 1.3.](ijnppy_pyu067_f0004){#F4}

### Effect of Early-Life Stress in FRL Hippocampus {#s20}

In FRL rats, MS differently regulated 19 spots and mass spectrometry identified 16 spots representing 25 distinct proteins/protein isoforms (five spots containing a mixture of two proteins and two spots containing three proteins; [Table 3](#T3){ref-type="table"}). The three top molecular and cellular functions identified by IPA analysis were free radical scavenging, small molecule biochemistry, and carbohydrate metabolism ([Figure 4C](#F4){ref-type="fig"} and [Table 4](#T4){ref-type="table"}). The top three pathways were superoxide radicals degradation, TCA cycle, and mitochondrial dysfunction ([Figure 4D](#F4){ref-type="fig"} and [Table 5](#T5){ref-type="table"}).

### Effects of Early-Life Stress in FSL Hippocampus {#s21}

MS differently modulated 19 spots in FSL and mass spectrometry identified 14 spots representing 23 distinct proteins/protein isoforms (five spots containing a mixture of two proteins, and one spot containing a mixture of five proteins; [Table 3](#T3){ref-type="table"}). The top three molecular and cellular functions, revealed by bioinformatic analysis with IPA, were protein trafficking, cellular assembly and organization, and cellular function and maintenance ([Figure 4E](#F4){ref-type="fig"} and [Table 4](#T4){ref-type="table"}). The top three canonical pathways were cell cycle (G2/M DNA damage checkpoint regulation), Myc-mediated apoptosis signaling, and ERK5 signaling ([Figure 4F](#F4){ref-type="fig"} and [Table 5](#T5){ref-type="table"}).

The biological functions and canonical pathways most relevant to the differently-expressed proteins in HPC were related to cellular remodeling, including cellular assembly and organization, cellular function and maintenance, cell morphology, and Rho GTPase signaling.

Network Analysis {#s22}
----------------

IPA analysis was used to determine networks of proteins significantly enriched in the various comparisons. IPA identified four networks in PFC/FC and four in HPC. The networks identified are shown in [Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}, respectively. The proteins involved and the network scores and biofunctions associated are shown in [Tables 6](#T6){ref-type="table"} and [7](#T7){ref-type="table"}, respectively.

![Significant pathway networks based on the proteins differently expressed between (A) Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (B) FRL after maternal separation (MS), and (C and D) FSL after MS, in prefrontal and frontal cortices. Protein nodes with a colored background correspond to the identified proteins in the various comparisons, while other proteins were added from the Ingenuity database. The intensity of node colors indicates the degree of upregulation (red) or downregulation (green). Fischer's exact test was used to calculate a *p*-value determining the probability that each biological function assigned to that network is due to chance alone.](ijnppy_pyu067_f0005){#F5}

![Significant pathway networks based on the differently expressed protein between (A) Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (B and C) FRL after maternal separation (MS), and (D) FSL after MS, in the hippocampus. Protein nodes with a colored background correspond to the identified proteins in the various comparisons, while other proteins were added from the Ingenuity database. The intensity of node colors indicates the degree of upregulation (red) or downregulation (green). Fischer's exact test was used to calculate a *p*-value determining the probability that each biological function assigned to that network is due to chance alone.](ijnppy_pyu067_f0006){#F6}

###### 

Networks of Proteins Identified by IPA in PFC/FC.

  Proteins in the network^a^                                                                                                                                                                                                                                                                           Score^b^   No. of focus proteins   High-level functions
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- ----------------------- -------------------------------------------------------------------------------
  FSL vs. FRL                                                                                                                                                                                                                                                                                                                             
  ALDOC, ATP6V0D1, DLAT, DLD, DNAJA4, DNAJB12, DNM1, FBXO11, FBXO45, FH, HNMT, HSPA8, HTT, IDH3A, INSR, MAPK3, NDUFS1, PDHB, PDHX, PRDX6, PRNP, SNAP25, Snare, SNPH, STX2, STX3, STXBP1, STXBP5, SYN3, SYTL3, TGFB1, TKT, TMEM132A, UBC, ZFAND2A                                                       32         11                      Cellular Function and Maintenance, Molecular Transport, Lipid Metabolism
  FRL+MS vs. FRL                                                                                                                                                                                                                                                                                                                          
  Akt, ALDOC, ASB9, CD3, DNAJB12, DNAJC6, DNAJC13, ETFB, FAM103A1, FBXO45, GAPDH, GNAO1, GPR158, HIF1A, HSPA8, HSPD1, IDH3A, IDH3B, IDH3G, IKBKG, MDH2, MPST, MYC, NCALD, NDUFS1, NGB, p85 (pik3r), PDHB, Pgk, PRDX6, RGS17, TMEM132A, TST, UBC, ZFAND2A                                               28         10                      Nucleic Acid Metabolism, Small Molecule Biochemistry, Carbohydrate Metabolism
  FSL+MS vs. FSL                                                                                                                                                                                                                                                                                                                          
  14-3-3, 14-3-3 (β,ε,ζ), 14-3-3 (β,γ,θ,η,ζ), 14-3-3 (η,θ,ζ), AANAT, Akt, ARRB2, ATP5A1, CBY1, CKMT1A/CKMT1B, CLTB, DENND4A, FAM13B, FAM53C, HECTD4, Histone h3, KIAA0101, LRFN1, MLXIP, Phb, PKM, PRDX6, RALGPS2, REM1, REM2, SAMD4A, SAMD4B, SH3BP5L, SYNPO2, TKT, TNF, YWHAB, YWHAG, YWHAH, YWHAZ   26         11                      Cell Morphology, Embryonic Development, Organ Development
  ACO2, ATP6V0D1, CSNK1G3, CYC1, GNAO1, GPR158, MDH1, NAPG, ND2, ND3, ND4L, NDUFA6, NDUFA8, NDUFA9, NDUFAF1, NDUFAF3, NDUFAF4, NDUFB6, NDUFS3, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV2, NGB, NOA1, NSF, PANK2, RGS17, SLC25A24, STXBP1, SYTL3, UBC, UQCR10, VDAC1                                       23         10                      Hereditary Disorder, Metabolic Disease, Cardiovascular Disease

^a^Proteins are indicated with gene name

^b^Scores \>3 were considered significant (p\<0.001)

FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; IPA, Ingenuity Pathways Analysis; MS, maternal separation; PFC/FC, prefrontal and frontal cortices.

###### 

Networks of Proteins identified by IPA in HPC.

  Proteins in the network^a^                                                                                                                                                                                                                                                                        Score^b^   No. of focus proteins   High-level functions
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- ----------------------- --------------------------------------------------------------------------------------------
  FSL vs. FRL                                                                                                                                                                                                                                                                                                                          
  ACTB, ACTG1, Actin, CAP2, CFL2, COTL1, CPNE2, Dmd, DPYSL2, EPS8L1, EPS8L2, GAS8, GNAO1, GOT2, GPR158, HIP1R, KCNQ2, KLHL17, MAF1, NCALD, NDUFS3, NEFL, NSF, PCYT1B, PHACTR1, PLS1, RAB8B, RGS17, SPTBN2, SSH1, SUCLA2, SULT2B1, TRPM7, UBC, XPO6                                                  26         9                       Cellular Assembly and Organization, Cancer, Connective Tissue Disorders
  FRL+MS vs. FRL                                                                                                                                                                                                                                                                                                                       
  26s Proteasome, ACTB, Actin, Akt, ATP5A1, Beta Tubulin, BLK, BMP, DNAJC6, DPYSL2, ENO2, FSH, GLUD1, GOT1, Hsp70, Hsp90, HSP, HSPA2, HSPA8, Insulin, MT3, NFkB (complex), NMDA Receptor, NTF3, p85 (pik3r), PACRG, RTN4R, SEMA3A, SNAP25, SOD1, SOD2, Sod, Spectrin, Tubulin, VIM                  30         12                      Free Radical Scavenging, Cell Morphology, Cellular Assembly and Organization
  AP2A1, ARHGDIA, ASPSCR1, ATP6V1A, ATP6V1B1, ATP6V1B2, ATP6V1E1, ATP6V1G2, AXIN1, CRMP1, DBI, GDI1, GLMN, IDH3A, IDH3B, IDH3G, IPO9, MECP2, MYC, NDUFS7, NDUFV2, NGLY1, NSFL1C, PHAX, Phb, ROCK2, RPL22, RTN4, SRP14, TUBA1A, UBC, UBXN6, UBXN2A, UBXN2B, VAV1                                     18         8                       Carbohydrate Metabolism, Nucleic Acid Metabolism, Small Molecule Biochemistry
  FSL+MS vs. FSL                                                                                                                                                                                                                                                                                                                       
  14-3-3, 14-3-3 (β,γ,θ,η,ζ), 14-3-3 (η,θ,ζ), 26s Proteasome, Actin, Akt, ATP5A1, Calmodulin, CAMK2A, CaMKII, CD3, DPYSL2, ERK, Histone h3, HSP, HSPA2, HSPA8, HSPD1, IMMT, INA, ITPKA, NDUFS1, NEFL, p85 (pik3r), PGK1, PI3K (complex), REM1, REM2, TCR, TUFM, YWHAB, YWHAG, YWHAH, YWHAQ, YWHAZ   48         17                      Protein Trafficking, Cellular Assembly and Organization, Cellular Function and Maintenance

^a^Proteins are indicated with gene name

^b^Scores \>3 were considered significant (p\<0.001)

FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; IPA, Ingenuity Pathways Analysis; MS, maternal separation.

Western Blot Analysis {#s23}
---------------------

To validate our proteomic results, we used Western analysis to measure the expression levels of six proteins of interest (NSF, ATP synthase alpha, aconitate hydratase, syntaxin-binding protein 1, DRP-2, and SNAP-25; [Figures 7](#F7){ref-type="fig"} and [Table 8](#T8){ref-type="table"}). Consistent with our 2-DE results, Western analysis confirmed significant decreases for NSF ([Figure 7A](#F7){ref-type="fig"}), ATP synthase alpha ([Figure 7B](#F7){ref-type="fig"}), and aconitate hydratase ([Figure 7C](#F7){ref-type="fig"}) levels in FSL+MS as compared with FSL+MS in PFC/FC. Western analysis also confirmed significantly increased levels of DRP-2 ([Figure 7E](#F7){ref-type="fig"}) in FSL compared to FRL, while SNAP-25 ([Figure 7F](#F7){ref-type="fig"}) showed a trend toward increases in FSL+MS compared to FSL+MS in the HPC ([Table 8](#T8){ref-type="table"}). Conversely, Western analysis for syntaxin-binding protein 1 ([Figure 7D](#F7){ref-type="fig"}) levels in FSL+MS compared to FSL in PFC/FC did not confirm the 2-DE results, showing decreased rather than increased level.

![Validation of two-dimensional gel electrophoresis results. (A) N-ethylmaleimide sensitive factor (NSF), (B) ATP synthase α, (C) aconitate hydratase, and (D) Syntaxin-binding protein 1 protein levels were analyzed in prefrontal and frontal cortices synaptosomes of Flinders Sensitive Line (FSL) and Flinders Resistant Line (FRL) after maternal separation (MS) by Western blot. Protein levels were normalized to β-actin and expressed as % relative to FSL rats. Data are presented as mean ± standard error of the mean (SEM; n = 6--8). Mann-Whitney test, \*p \< 0.01; \*\*p \< 0.001. (E) Dihydropyrimidinase-related protein 2 (DRP-2) protein levels were analyzed in hippocampus (HPC) synaptosomes of FRL and FSL by Western blot. Protein levels were normalized to β-actin and expressed as % relative to FRL rats. Data are presented as mean ± SEM (n = 9--12). Mann-Whitney test, \*\*p \< 0.001. [(F)]{.ul} Synaptosomal-associated protein 25 (SNAP-25) protein levels were analyzed in HPC synaptosomes of FRL and FRL after MS by Western blot. Protein levels were normalized to β-actin and expressed as % relative to FRL rats. Data are presented as mean ± SEM (n = 10--11). Mann-Whitney test.](ijnppy_pyu067_f0007){#F7}

###### 

Proteins Selected for Western Blotting Validations.

  Proteins                          Fold change WB   *p*-value WB^a^   Fold change 2-DE spots
  --------------------------------- ---------------- ----------------- ------------------------
  FSL+MS vs. FSL (PFC/FC)                                              
  NSF                               -1.23            *p* = 0,0019      -1.2
  ATP synthase subunit alpha^(b)^   -1.25            *p* = 0,0080      -2.3; -1.8
  Aconitate hydratase               -1.31            *p* = 0,0002      -1.3
  Syntaxin-binding protein 1        -1.25            *p* = 0,0047      1.9
  FSL vs. FRL (HPC)                                                    
  DRP-2                             1.45             *p* = 0,0003      1.8
  FRL+MS vs. FRL (HPC)                                                 
  SNAP-25                           1.12             *p* = 0,0726      1.3

^a^Unpaired two-tailed Mann-Whitney test *p*-value

^b^Multiple spots of this protein were dysreguated in 2-DE

2-DE, two-dimensional gel electrophoresis; ATP, adenosine triphosphate; DRP-2, dihydropyrimidinase-related protein 2; FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; MS, maternal separation; NSF, N-ethylmaleimide sensitive factor; PFC/FC, prefrontal and frontal cortices; SNAP-25, synaptosomal-associated protein 25; WB, Western blot analysis.

Discussion {#s24}
==========

Early-life stress has been recognized as a risk factor for depression ([@CIT0021]). In the present study we employed a standard MS protocol to analyze the impact of early-life adverse events on the proteomic profile of purified synaptic terminals in the FSL/FRL genetic animal model of depression. We have previously explored the outcome of the interaction of early-life stress with the background of vulnerability of FSL rats. We found marked alterations in key regulators of presynaptic release/neurotransmission in the basal FSL rats as a result of early-life stress, such as blunted responses to the stress of synaptic Erk-MAP kinases. These findings suggested the occurrence of synaptic dysfunction in the GxE model. This was accompanied by remodeling of N-methyl-D-aspartate receptor-dependent hippocampal synaptic plasticity ([@CIT0059]; [@CIT0044]). At the peripheral level (serum), proteomic analysis evidenced changes in pathways related with inflammation and regulation of metabolism ([@CIT0008]).

In the present work, for the first time, we carried out a global proteomic analysis of the FSL/FRL model at the synaptic level.

Here we used a bioinformatic approach to analyze the functional relevance of the numerous proteins found dysregulated in FSL versus FRL following early-life stress. Interestingly, we found a brain region--specific pattern of pathway enrichment. Indeed, we found that expression of the proteins involved in energy metabolism pathways was mostly changed in the PFC/FC area, suggesting that in this area energy metabolism is particularly affected by genetic vulnerability and early-life stress. This is not surprising since the brain is a high energy-demanding structure, especially the cortical areas, where glutamatergic synapses and neurotransmission are predominant ([@CIT0004]). On the contrary, we found that expression of the proteins related to cellular remodeling pathways was mainly changed in the HPC. Indeed, numerous studies have highlighted the notion that changes in brain morphology represent a key factor in the response to stress, pathophysiology of depression, and antidepressant action. Indeed, volumetric changes in the PFC/FC and HPC have been reported both in depressed patients and animal models of depression. Furthermore, stress is able to induce dendritic retraction and reduction of spine number, thus affecting synaptic transmission ([@CIT0038]; [@CIT0032]; [@CIT0020]; [@CIT0060]; [@CIT0065]).

Basal Differences Between FSL and FRL in Prefrontal and Frontal Cortices {#s25}
------------------------------------------------------------------------

In the present work, we found a number of proteins involved in energy metabolism pathways differently expressed in the basal comparison of FSL versus FRL in PFC/FC synaptosomes. Indeed, we found the energy metabolism proteins isocitrate dehydrogenase subunit alpha, fructose bisphosphate aldolase C and pyruvate dehydrogenase subunit beta were upregulated in FSL rats versus their control FRL rats. These modifications are in line with previous clinical and preclinical studies. Fructose bisphosphate aldolase C was found to be upregulated in the frontal cortices of patients with MD in two proteomic studies ([@CIT0028]; [@CIT0003]), while pyruvate dehydrogenase (subunit alpha) was found to increase in total homogenate of PFC/FC of FSL in a previous proteomic study ([@CIT0055]). Moreover, mitochondrial disorders (including mutation in the gene coding for pyruvate dehydrogenase subunit alpha) have been diagnosed in depressed adolescents ([@CIT0031]).

In addition, we found that several proteins involved in synaptic function were dysregulated as a consequence of genetic vulnerability. In basal FSL versus FRL PFC/FC synaptosomes, proteins related to synaptic vesicle fusion and recycling were downregulated. Indeed, we found lower levels of syntaxin-binding protein 1 (also known as Munc-18), a protein involved in synaptic vesicle exocytosis ([@CIT0026]); dynamin 1, a GTPase involved in clathrin-coated synaptic vesicles budding; and heat shock cognate 71 (also known as heat shock cognate 70, HSPA8), an ATPase involved in chaperoning SNAP-25 during synaptic function and in the clathrin uncoating of recycled vesicles ([@CIT0063]; [@CIT0039]). Interestingly, a recent hypothesis suggested that clathrin-dependent membrane and protein trafficking might be core processes involved in the pathophysiology of schizophrenia and bipolar disorder ([@CIT0062]). Furthermore, a proteomic study that analyzed the postmortem dorsolateral PFC from depressed patients, found reduced phosphorylation of dynamin-1 at different phosphorylation sites ([@CIT0037]).

Effect of Early-Life Stress in FRL Prefrontal and Frontal Cortices {#s26}
------------------------------------------------------------------

Early-life stress had an important effect on brain metabolic pathways in PFC/FC FRL rats. Firstly, we found that the genetic vulnerability in FSL and early-life stress in FRL result in a similar effect on pyruvate dehydrogenase beta (i.e., increased expression), again consistent with the previous proteomic study of FSL/FRL ([@CIT0055]). Secondly, we found that early-life stress in FRL synaptosomes reduced the expression of several proteins involved in glycolysis, tricarboxilic acid cycle and oxidative phosphorylation (glyceraldehyde-3-phosphate dehydrogenase, fructose-bisphosphate aldolase C, isocitrate dehydrogenase, malate dehydrogenase, NADH-ubiquinone oxidoreductase 75kDa), suggesting a reduction of energy production. Indeed, a previous proteomic work on maternally-separated rats reported a downregulation of isocitrate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase similar to what we found here for FRL rats subjected to the same protocol of stress ([@CIT0036]). Interestingly, a previous proteomic study from our group showed a similar downregulation of several mitochondrial and energy metabolism proteins in PFC/FC synaptosomes following induction of learned helplessness in rats ([@CIT0035]).

Effect of Early-Life Stress in FSL Prefrontal and Frontal Cortices {#s27}
------------------------------------------------------------------

Early MS had a deeper impact on the synaptic proteome of FSL compared with FRL rats, with twice the number of proteins found dysregulated. In FSL, we found a decrease in proteins related to energy metabolism, such as components of oxidative phosphorylation complexes I (NADH-ubiquinone oxidoreductases), III (cytochrome C1), and V (ATP synthase alpha), malate dehydrogenase, and aconitate hydratase. Notably, neuroimaging studies have shown reduced levels of ATP in the brains of patients with mood disorders compared to controls, thus indicating lower metabolic brain activity in depressed patients ([@CIT0041]). Indeed, we found reduced levels of ATP synthase alpha in FSL rats subjected to MS. On the contrary, we found increased levels of creatine kinase, the enzyme that catalyzes the conversion of creatine to its high energy phosphorylated form phosphocreatine with use of ATP ([@CIT0002]). This upregulation of creatine kinase in response to early-life stress could be explained by a compensatory mechanism for the possible reduction of ATP, due to lower ATP synthase alpha level.

Early-life stress also reduced expression of two proteins involved in synaptic transmission: NSF, an ATPase involved in the disassembly of SNARE complexes and synaptic vesicle recycling ([@CIT0067]) and clathrin light chain B. This piece of evidence further supports the involvement of clathrin-mediated endocythosis/trafficking in the pathophysiology of psychiatric diseases ([@CIT0062]).

Basal Differences Between FSL and FRL in Hippocampus {#s28}
----------------------------------------------------

In the present study we report modifications in the expression of several proteins involved in cellular remodeling processes; it is interesting to note that these modifications were found mainly in HPC. Actin is a key cytoskeletal protein involved in axon guidance, synapse development, and synaptic plasticity ([@CIT0077]; [@CIT0073]; [@CIT0012]). Here we found a dysregulation of several actin isoforms in basal FSL versus FRL rats. This result is in agreement with a previous proteomic work in the same GxE animal model, that analyzed the total homogenate of PFC/FC and HPC ([@CIT0055]). Moreover, in the present study, neurofilament light neuropeptide (NEFL), an intermediate neurofilament protein involved in axonal and dendritic growth ([@CIT0078]), was found to be modulated by genetic vulnerability (FSL vs. FRL).

Effect of Early-Life Stress in FRL Hippocampus {#s29}
----------------------------------------------

In FRL, early-life stress modulated levels of actin isoforms in HPC synaptosomes; similar modifications have been found previously in the HPC total homogenate of FRL rats subjected to the same protocol of MS ([@CIT0055]). In addition, we found a downregulation of DRP-2 in both FRL and FSL (see below). Notably, we found an increased expression of the SNARE-complex protein SNAP-25 and downregulation of three distinct protein isoforms of HSPA8, a component of the chaperone complex that prevents misfolding of SNAP-25 ([@CIT0063]; [@CIT0066]).

Effect of Early-Life Stress in FSL Hippocampus {#s30}
----------------------------------------------

NEFL and alpha-internexin, other intermediate neurofilament proteins involved in axonal and dendritic growth ([@CIT0078]), were found to be modulated by early-life stress in FSL HPC. In line with the present findings, modifications of these two proteins were also found in other animal models of depression, such as the psychosocial stress ([@CIT0006]) and the learned helplessness model ([@CIT0057]), or after long-term treatment with the stress hormone corticosterone ([@CIT0079]). Notably, enriched environment, physical exercise, chronic electroconvulsive shock, or treatment with valproic acid (but not fluoxetine) modulate NEFL levels in rodents ([@CIT0068]; [@CIT0014]; [@CIT0017]; [@CIT0064]).

In the present study, we found additional evidence involving cytoskeleton-remodeling pathways as an outcome of early-life stress. The 14-3-3 proteins are adaptor proteins involved in intracellular signaling, cell growth, apoptosis, ion channel function, and neurotransmission ([@CIT0005]). Moreover, 14-3-3 proteins interact with NEFL and have a role in NEFL disassembly ([@CIT0040]). The increased levels of 14-3-3 proteins, found here in both PFC/FC and HPC synaptosomes following MS in FSL rats, suggest increased disassembly of neurofilaments and possibly altered dynamics of neurofilaments at the synaptic level. Increased levels of 14-3-3 have also been found in the chronic unpredictable stress model of depression ([@CIT0043]). Interestingly, 14-3-3 proteins have been found to be altered in schizophrenia and bipolar disorder ([@CIT0001]) after treatment with the antidepressant fluoxetine, or the mood stabilizers valproate and lithium ([@CIT0001]; [@CIT0046]).

DRP-2 (also known as CRMP2) is a cytosolic protein involved in axonal guidance and growth, cell migration, signal transduction, and neuronal differentiation ([@CIT0013]; [@CIT0035]; [@CIT0025]). DRP-2 interacts with the cytoskeleton proteins tubulin, actin, and vimentin, and is able to regulate microtubule dynamics, based on its phosphorylated state, by stabilizing/destabilizing tubulin heterodimer ([@CIT0029]). We found DRP-2 downregulated following MS in both FRL and FSL rats. Two proteomic studies of post-mortem brain of depressed patients found DRP-2 downregulated as in the present study ([@CIT0028]; [@CIT0037]), while a third found DRP-2 upregulated ([@CIT0003]). Involvement of DRP-2 in the pathophysiology of depression is confirmed also by several preclinical studies ([@CIT0030]; [@CIT0007]; [@CIT0035]).

In the present work, as already mentioned, the changes in proteins involved in energy metabolism were found mainly in PFC/FC; however, in HPC we also found a reduction of ATP synthase alpha following early-life stress in FSL, similar to what we observed in PFC/FC.

Network Analysis {#s31}
----------------

In genetically complex diseases such as depression, multiple genetic factors of small effect interact among themselves and with environmental factors to precipitate the pathology ([@CIT0074]). In this context it is important not only to identify the many genes and proteins involved but also to unveil the molecular pathways associated. It is interesting to note that in the networks related to basal comparison in both PFC/FC ([Figure 5A](#F5){ref-type="fig"}) and HPC ([Figure 6A](#F6){ref-type="fig"}), a major hub is formed by ubiquitin C (Ubc). Ubc, in combination with the 26S proteasome, has a central role in proteolytic degradation of substrates in multiple processes but is involved also in non-proteolytic regulatory mechanisms, including membrane protein endocytosis and intracellular trafficking ([@CIT0023]). Moreover, the ubiquitin-proteasome pathway has been also involved in synaptic plasticity ([@CIT0022]). In the basal PFC/FC network ([Figure 5A](#F5){ref-type="fig"}), Ubc is connected to a cluster formed by proteins involved in synaptic function, such as dynamin 1, syntaxin-binding protein 1, and synaptosomal associated protein of 25kDa. Moreover, Ubc is also linked through multiple connections to a cluster of proteins that form the pyruvate dehydrogenase complex, a key mitochondrial enzyme that links the glycolysis to the tricarboxylic acid cycle ([@CIT0052]). Instead, in the network related to the basal comparison in HPC ([Figure 6A](#F6){ref-type="fig"}), Ubc is connected to a large cluster of proteins that interact with the cytoskeletal protein actin. Therefore, network analysis of the present results shows cross-interaction of pathways for energy metabolism, cytoskeleton remodeling, and synaptic transmission.

Validation by Western Blot Analysis {#s32}
-----------------------------------

Validation of dysregulated proteins by independent methods is an important step of a proteomic study. In this work, we used Western analysis to confirm the differential expression of six proteins found dysregulated in the present study. These proteins were selected based on expression levels observed in 2-DE maps, fold-changes, and availability of commercial antibodies. The six proteins were NSF, ATP synthase alpha, aconitate hydratase, syntaxin-binding protein 1, DRP-2, and SNAP-25. Our results show a strong agreement with the 2-DE expression changes, with the exception of syntaxin-binding protein 1, which showed change in the opposite direction (decrease). This discrepancy could be explained by the fact that 2-DE is able to detect the differential expression of single isoforms or post-translational modifications of a protein, while Western analysis can measure only the total amount of that protein. Indeed, syntaxin-binding protein 1 has two alternatively-spliced isoforms and several phosphorylation sites ([@CIT0033]). It is possible that 2-DE experiment highlighted a change in protein expression of a low-abundant post-translational modified isoform. Furthermore, in a previous work we found a similar reduction of syntaxin-binding protein 1 in HPC synaptosomes from FSL subjected to MS by using Western blotting analysis ([@CIT0044]). The case for syntaxin-binding protein 1 in this study highlights the importance of protein post-translational modifications. This is exemplified by the finding that some proteins appear on gels in multiple spots. For instance, HSPA8 protein appears on the gel in [Figure 2B](#F2){ref-type="fig"} in at least 4 spots (1903, 1907, 2901, 2902) with same molecular weight, and 1 spot (1905) with higher molecular weight. The first 4 spots are likely to be different post-translational modifications of the same protein. Therefore, changes in post-translational modifications can be at least as important as expression changes in regulating protein function, and in turn the phenotype of FSL.

Conclusion {#s33}
----------

Taken together, our results indicate an overall dysregulation of proteins related to energy metabolism in PFC/FC of FSL/FRL as a consequence of genetic vulnerability and early-life stress. Indeed, mitochondrial dysfunction and mitochondrial regulation of energy metabolism could be central in the pathophysiology of stress-related pathologies such as depression ([@CIT0042]; [@CIT0054]). In addition, the dysregulation of structural proteins found here in HPC suggests that genetic vulnerability and early-life stress may cause perturbation of cytoskeleton dynamics at the synaptic level, which is now being recognized as a cellular/molecular feature of depression ([@CIT0045]; [@CIT0073]).

Interestingly, it was recently found that the depressed-like phenotype of FSL rats could be linked to hyperfunctioning of a G protein--coupled, inward rectifying potassium channel (GIRK). Indeed, GIRK knockout mice showed reduced hypothermic responses to virtually all drugs that typically induce greater hypothermic response in FSL rats. Possible hyperfunctioning of GIRK could explain the increased sensitivity to multiple G protein--coupled receptors in FSL ([@CIT0051]). We wonder whether the marked proteomic changes we found in FSL could be linked in some way to GIRK abnormalities in this rat line. Additional experiments are required to explore this interesting hypothesis.
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